Elevator pitch
AccuRXy in three slides
An overview. The full deck holds the detail.
The problem and the product01 / 3
Medication harm is costly and preventable, yet training and governance remain manual
$42bn
Lost every year to medication errors, against a WHO goal to halve severe avoidable harm.
What is still done by hand
- Universities write and check learning cases one at a time, never fast enough for what students need
- In pharmacies, incident reports, follow-up actions, procedures and training records sit in paper and spreadsheets
- So an owner or chief pharmacist has no single view of risk before an inspection
What AccuRXy is
- Educate, for universities: realistic scenario practice at the volume students ask for, approved by their own faculty
- Regulate, for pharmacies: report, investigate and correct medication incidents in one workflow, inspection-ready
- One engine behind both, so every scenario records the guidance it came from and who approved it
Where we are: building and in trial preparation, with four trials committed across universities and Irish pharmacy.
Who pays, and how much02 / 3
Two products, two distinct buyers, priced per seat and per site
€89
Educate: per student per year
Universities and colleges
€3,000
Regulate: per pharmacy site per year
Owners and superintendents
Illustrative annual recurring revenue
- €107k to €178k a year from 3 to 5 schools on Educate
- €150k a year from 50 pharmacy sites on Regulate
Why both, not one
- The academic sale builds credibility and the evidence base
- The pharmacy sale pays more per customer and is closer to revenue
- Neither needs a second product to be built
These are modelled scenarios and price points under test, not forecasts or commitments.
The ask03 / 3
Seeking €900k at Seed to convert four trials into first paid contracts
€900k
Seed round
Target close June to August 2027
4 trials
Academic and Regulate
Running to September 2027
Aug 2027
Intent to pay
3 to 5 institutions
Use of funds
Product and trials50% · €450k
Go-to-market30% · €270k
IP, legal and contingency20% · €180k
What the round proves
- Documented evidence that educators save time and students improve
- A Regulate buying decision with an Irish pharmacy operator
- Measured production cost per scenario and a costed business model
- Three to five institutions ready to pay
AccuRxy
Safe Practice
